Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Comparison of techniques for monitoring infliximab and antibodies against infliximab in Crohn's disease

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Steenholdt, Casper ; Ainsworth, Mark A ; Tovey, Michael ; Klausen, Tobias W ; Thomsen, Ole O ; Brynskov, Jørn ; Bendtzen, Klaus. / Comparison of techniques for monitoring infliximab and antibodies against infliximab in Crohn's disease. In: Therapeutic Drug Monitoring. 2013 ; Vol. 35, No. 4. pp. 530-8.

Bibtex

@article{56e87e6e03644ece99d4e44c5b99ec1c,
title = "Comparison of techniques for monitoring infliximab and antibodies against infliximab in Crohn's disease",
abstract = "Several techniques are used to measure infliximab (IFX) and anti-IFX antibodies (Abs) in Crohn's disease. The aim of this study was to compare different assays for this purpose.",
author = "Casper Steenholdt and Ainsworth, {Mark A} and Michael Tovey and Klausen, {Tobias W} and Thomsen, {Ole O} and J{\o}rn Brynskov and Klaus Bendtzen",
year = "2013",
month = aug,
doi = "10.1097/FTD.0b013e31828d23c3",
language = "English",
volume = "35",
pages = "530--8",
journal = "Therapeutic Advances in Drug Safety",
issn = "0163-4356",
publisher = "Lippincott Williams & Wilkins",
number = "4",

}

RIS

TY - JOUR

T1 - Comparison of techniques for monitoring infliximab and antibodies against infliximab in Crohn's disease

AU - Steenholdt, Casper

AU - Ainsworth, Mark A

AU - Tovey, Michael

AU - Klausen, Tobias W

AU - Thomsen, Ole O

AU - Brynskov, Jørn

AU - Bendtzen, Klaus

PY - 2013/8

Y1 - 2013/8

N2 - Several techniques are used to measure infliximab (IFX) and anti-IFX antibodies (Abs) in Crohn's disease. The aim of this study was to compare different assays for this purpose.

AB - Several techniques are used to measure infliximab (IFX) and anti-IFX antibodies (Abs) in Crohn's disease. The aim of this study was to compare different assays for this purpose.

U2 - 10.1097/FTD.0b013e31828d23c3

DO - 10.1097/FTD.0b013e31828d23c3

M3 - Journal article

C2 - 23765033

VL - 35

SP - 530

EP - 538

JO - Therapeutic Advances in Drug Safety

JF - Therapeutic Advances in Drug Safety

SN - 0163-4356

IS - 4

ER -

ID: 39736412